SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivo Bio Tech informs about newspaper clippings

15 Sep 2025 Evaluate

Vivo Bio Tech has informed that it enclosed the Newspaper clippings for publication of notice about Special Window for Re-lodgement of Transfer Requests of Physical Shares published in Financial Express (English) & Nava Telangana (Telugu) on September 15, 2025 pursuant to SEBI Circular No. SEBI/HO/MIRSD/MIRSDPoD/P/CIR/2025/97, dated July 02, 2025.

The above information is a part of company’s filings submitted to BSE.

Vivo Bio Tech Share Price

28.59 0.79 (2.84%)
24-Apr-2026 12:32 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.70
Dr. Reddys Lab 1331.25
Cipla 1289.40
Zydus Lifesciences 930.55
Lupin 2270.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×